Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HAUS augmin-like complex subunit 1 (HAUS1) is one of the eight subunits comprising the human augmin (HAUS) complex, a cytoplasmic, microtubule-associated protein assembly critical for microtubule nucleation and the proper formation of the mitotic spindle during cell division[1][2][3][4][5]. HAUS1 facilitates the recruitment of the γ-tubulin ring complex (γ-TuRC) to existing spindle microtubules, enabling the formation of branched, high-density microtubule networks required for accurate chromosomal segregation[3][5]. Its functions extend beyond mitosis, participating in maintaining microtubule organization in differentiated, non-dividing cells such as neurons, and playing possible roles in tissue remodeling and development (e.g., heart, muscle)[1]. HAUS1 has been implicated in oncogenic fusion events, such as NPM1-HAUS1 translocations in acute myeloid leukemia, and altered expression in other disease contexts[1]. While HAUS1 is essential for cellular homeostasis, it is not currently a therapeutic target or receptor, and there are no known drug interactions or established mechanisms of pharmacological targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HAUS augmin-like complex subunit 1 (HAUS1).